IRMD
IRadimed Corporation
Platform & Compounding FCF
A
88.4 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
19.3%
-
Operating Margin Trend
+1.61 pp/yr
-
5yr Avg ROE
20.1%
-
5yr Share-Count CAGR
0.7%
-
5yr Revenue CAGR
21.5%
-
5yr EPS CAGR
73.9%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
18.7%
-
5yr FCF/NI Conversion
0.75x
-
Net Debt / EBITDA
-1.66x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
47.78
Stability
Weight: 5%
C-
49
-
EPS Volatility (σ/μ)
0.66
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
5
1 of 2 gurus held; 1 trimmed; 1 full exit.
- Holders
- 1
-1
- Avg Δ position
-
-16.8%
- New buys
- 0
- Full exits
- 1